Nuveen’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-792,433
| Closed | -$9.79M | – | 3340 |
|
|
2024
Q4 | $9.79M | Buy |
792,433
+1,881
| +0.2% | +$21.5K | ﹤0.01% | 1616 |
|
|
2024
Q3 | $9M | Buy |
790,552
+546,340
| +224% | +$5.48M | ﹤0.01% | 1673 |
|
|
2024
Q2 | $1.74M | Buy |
244,212
+16,555
| +7% | +$127K | ﹤0.01% | 2454 |
|
|
2024
Q1 | $1.53M | Buy |
227,657
+61,259
| +37% | +$421K | ﹤0.01% | 2519 |
|
|
2023
Q4 | $1.08M | Buy |
166,398
+1,531
| +0.9% | +$9.87K | ﹤0.01% | 2694 |
|
|
2023
Q3 | $1.56M | Sell |
164,867
-2,155
| -1% | -$25.9K | ﹤0.01% | 2396 |
|
|
2023
Q2 | $2.33M | Buy |
167,022
+4,430
| +3% | +$75.5K | ﹤0.01% | 2275 |
|
|
2023
Q1 | $3.05M | Sell |
162,592
-7,703
| -5% | -$127K | ﹤0.01% | 2160 |
|
|
2022
Q4 | $2.35M | Sell |
170,295
-5,890
| -3% | -$90.2K | ﹤0.01% | 2307 |
|
|
2022
Q3 | $3.37M | Sell |
176,185
-216,411
| -55% | -$3.94M | ﹤0.01% | 2124 |
|
|
2022
Q2 | $5.99M | Sell |
392,596
-53,682
| -12% | -$794K | ﹤0.01% | 1827 |
|
|
2022
Q1 | $9.66M | Sell |
446,278
-226,171
| -34% | -$4.61M | ﹤0.01% | 1663 |
|
|
2021
Q4 | $16.5M | Sell |
672,449
-176,552
| -21% | -$5.05M | ﹤0.01% | 1345 |
|
|
2021
Q3 | $17.8M | Sell |
849,001
-93,208
| -10% | -$2.25M | 0.01% | 1348 |
|
|
2021
Q2 | $24.2M | Sell |
942,209
-77,180
| -8% | -$1.65M | 0.01% | 1214 |
|
|
2021
Q1 | $18.6M | Buy |
1,019,389
+493,121
| +94% | +$8.19M | 0.01% | 1378 |
|
|
2020
Q4 | $6.07M | Buy |
526,268
+132,733
| +34% | +$1.21M | ﹤0.01% | 1969 |
|
|
2020
Q3 | $3M | Buy |
393,535
+11,607
| +3% | +$87.9K | ﹤0.01% | 2186 |
|
|
2020
Q2 | $2.51M | Sell |
381,928
-3,804
| -1% | -$21.2K | ﹤0.01% | 2241 |
|
|
2020
Q1 | $1.97M | Buy |
385,732
+102,811
| +36% | +$622K | ﹤0.01% | 2200 |
|
|
2019
Q4 | $2.17M | Buy |
282,921
+40,853
| +17% | +$238K | ﹤0.01% | 2392 |
|
|
2019
Q3 | $1.28M | Buy |
242,068
+44,488
| +23% | +$276K | ﹤0.01% | 2591 |
|
|
2019
Q2 | $1.11M | Buy |
+197,580
| New | +$815K | ﹤0.01% | 2693 |
|
|
2016
Q2 | – | Sell |
-1,955
| Closed | -$6 | – | 1426 |
|
|
2016
Q1 | $6 | Hold |
1,955
| – | – | ﹤0.01% | 1392 |
|
|
2015
Q4 | $16 | Hold |
1,955
| – | – | ﹤0.01% | 1499 |
|
|
2015
Q3 | $14 | Hold |
1,955
| – | – | ﹤0.01% | 1535 |
|
|
2015
Q2 | $18 | Hold |
1,955
| – | – | ﹤0.01% | 1583 |
|
|
2015
Q1 | $18K | Hold |
1,955
| – | – | ﹤0.01% | 1575 |
|
|
2014
Q4 | $19K | Sell |
1,955
-140
| -7% | -$1.41K | ﹤0.01% | 1603 |
|
|
2014
Q3 | $20K | Hold |
2,095
| – | – | ﹤0.01% | 1583 |
|
|
2014
Q2 | $28K | Hold |
2,095
| – | – | ﹤0.01% | 1586 |
|
|
2014
Q1 | $28K | Buy |
2,095
+290
| +16% | +$3.82K | ﹤0.01% | 1575 |
|
|
2013
Q4 | $18K | Buy |
1,805
+131
| +8% | +$1.23K | ﹤0.01% | 1563 |
|
|
2013
Q3 | $16K | Buy |
+1,674
| New | +$16.6K | ﹤0.01% | 1468 |
|
Other funds holding CDMO
Nuveen's CDMO Position: Q1 2025 in Review
Nuveen sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 792,433 shares — an estimated $9.79M sold.
Nuveen first reported a position in CDMO in Q3 2013 and held it in 34 quarters. The position peaked at $24.2M in Q2 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Nuveen reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Nuveen sold 792,433 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $9.79M.
- Nuveen first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2013 and held it in 34 quarters.
- Nuveen's Avid Bioservices, Inc. Common Stock position peaked at $24.2M in Q2 2021.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Nuveen's 13F filing for Q1 2025, filed 12 May 2025.